Linked Life Data

15098881

Source:http://linkedlifedata.com/resource/pubmed/id/15098881

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-4-21
pubmed:abstractText
Subcutaneous estrogen replacement involves placement of estradiol pellets in the subcutaneous area of the lower abdomen or buttocks. Physiologic levels of estradiol are obtained, and follicle stimulating hormone levels are suppressed, similar to values found during premenopause. Insertion is a minor office procedure, with the usual starting dose of 25 mg of estradiol placed; it provides climacteric symptom relief and osteoporosis protection as well as the many other benefits of estrogen replacement. Supplementation with testosterone pellets can be performed, if indicated, at the same time. Patients with an intact uterus require progesterone therapy to protect the endometrium, as do patients using other forms of estrogen replacement. Return of climacteric symptoms, combined with serum levels, can be used to determine the timing of redosing, which is about every 6 months for most patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0024-7758
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
139-42
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Subcutaneous estrogen replacement therapy.
pubmed:affiliation
Department of Obstetrics and Gynecology, Keesler Medical Center, Keesler Air Force Base, Mississippi 39534, USA. stephen.jones@keesler.af.mil
pubmed:publicationType
Journal Article, Review